Cargando…
Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis
BACKGROUND: Pancreatic cancer is one of the most lethal cancers worldwide. The IAPs function as E3 ubiquitin ligases and contribute to pancreatic cancer initiation, progression, and metastasis. Although IAP-targeted therapies have been developed and shown anticancer efficacy in preclinical settings,...
Autores principales: | Qi, Simin, Guan, Xiaoqing, Zhang, Jia, Yu, Dehua, Yu, Xuefei, Li, Qinglin, Yin, Wenjuan, Cheng, Xiang-Dong, Zhang, Weidong, Qin, Jiang-Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908661/ https://www.ncbi.nlm.nih.gov/pubmed/35272681 http://dx.doi.org/10.1186/s12943-022-01538-4 |
Ejemplares similares
-
Ubiquitin control of S phase: a new role for the ubiquitin conjugating enzyme, UbcH7
por: Whitcomb, Elizabeth A, et al.
Publicado: (2009) -
Structural analysis of recombinant human ubiquitin-conjugating enzyme UbcH5c
por: Wu, Fangshu, et al.
Publicado: (2017) -
Overexpression of the E2 ubiquitin–conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation
por: van Ree, Janine H., et al.
Publicado: (2010) -
Molecular Simulation Elaborating the Mechanism of 1β-Hydroxy Alantolactone Inhibiting Ubiquitin-Conjugating Enzyme UbcH5s
por: Xu, Youdong, et al.
Publicado: (2020) -
Segregating out UbcH10's role in tumorigenesis
por: Short, Ben
Publicado: (2010)